PAPADOPOULOS STELIOS Insider Trades

Insider Trading History

Track insider trading activity for PAPADOPOULOS STELIOS. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Exelixis
Exelixis EXEL
Director
Holding Value $61.5M 1,197,595 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 8,367 shares
$50.03
$51.34
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $505k 217,578 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45k 17,578 shares
$2.56
$2.32
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $151k 65,000 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 65,000 shares
$1.65
$2.32
Exelixis
Exelixis EXEL
Director
Holding Value $61.1M 1,189,228 shares
Last Trade
Nov 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.36M 100,000 shares
$43.55
$51.34
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.51M 184,489 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $527k 64,635 shares
Last Trade
Jun 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$7.97M 976,253 shares
$8.16
$8.16
Exelixis
Exelixis EXEL
Director
Holding Value $66.2M 1,289,228 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$418k 9,812 shares
$42.60
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $0 0 shares
Last Trade
May 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.69M 36,508 shares
$46.26
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $66.7M 1,300,050 shares
Last Trade
May 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.69M 36,508 shares
$46.26
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $65.7M 1,279,416 shares
Last Trade
May 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$704k 15,874 shares
$44.35
$51.34
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $8.49M 1,040,888 shares
Last Trade
Apr 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 62,500 shares
$7.98
$8.16
Ovid Therapeutics
Ovid Therapeutics OVID
Director
Holding Value $209k 90,000 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.1k 90,000 shares
$0.49
$2.32
Exelixis
Exelixis EXEL
Director
Holding Value $65.7M 1,279,416 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 18,838 shares
$21.69
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $65.3M 1,272,015 shares
Last Trade
May 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 11,686 shares
$19.57
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $64.7M 1,260,578 shares
Last Trade
May 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$240k 11,437 shares
$21.00
$51.34
Exelixis
Exelixis EXEL
Director
Holding Value $0 0 shares
Last Trade
May 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 11,686 shares
$19.57
$51.34
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $490k 60,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 60,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $245k 30,000 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.3k 30,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $7.98M 978,388 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 250,000 shares
$2.44
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $122k 15,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 15,000 shares
$1.36
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up